SILVADENE
NDC 61570-131, silver sulfadiazine, cream, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 61570-131
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA017381
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61570-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILVER SULFADIAZINE10 mg/g
Pharmacologic classes
Sulfonamide Antibacterial [EPC]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61570-131-20 | 61570013120 | 1 TUBE in 1 CARTON (61570-131-20) / 20 g in 1 TUBE |
| 61570-131-25 | 61570013125 | 1 TUBE in 1 CARTON (61570-131-25) / 25 g in 1 TUBE |
| 61570-131-40 | 61570013140 | 400 g in 1 JAR (61570-131-40) |
| 61570-131-50 | 61570013150 | 50 g in 1 JAR (61570-131-50) |
| 61570-131-55 | 61570013155 | 1 TUBE in 1 CARTON (61570-131-55) / 50 g in 1 TUBE |
| 61570-131-85 | 61570013185 | 1 TUBE in 1 CARTON (61570-131-85) / 85 g in 1 TUBE |
| 61570-131-98 | 61570013198 | 1000 g in 1 JAR (61570-131-98) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c437213a-1cd4-445e-a39f-bbcacb9f746fNADAC price for package 61570013120
GET /v1/drugs/nadac/61570013120NADAC price for package 61570013125
GET /v1/drugs/nadac/61570013125NADAC price for package 61570013140
GET /v1/drugs/nadac/61570013140NADAC price for package 61570013150
GET /v1/drugs/nadac/61570013150NADAC price for package 61570013155
GET /v1/drugs/nadac/61570013155NADAC price for package 61570013185
GET /v1/drugs/nadac/61570013185
Use it
Look up 61570-131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61570-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61570-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.